Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Ana Gleisner

Concepts (331)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Neoplasms
38
2025
633
5.200
 Why?
Hepatectomy
38
2025
209
5.190
 Why?
Carcinoma, Hepatocellular
23
2025
270
4.600
 Why?
Pancreatic Neoplasms
24
2024
873
4.230
 Why?
Adenocarcinoma
25
2024
888
3.670
 Why?
Sentinel Lymph Node
8
2022
42
2.860
 Why?
Laparoscopy
9
2024
450
2.570
 Why?
Melanoma
12
2022
722
2.540
 Why?
Skin Neoplasms
12
2022
818
2.440
 Why?
Pancreaticoduodenectomy
11
2024
158
2.270
 Why?
Cholangiocarcinoma
10
2025
77
2.200
 Why?
Bile Duct Neoplasms
10
2025
99
2.120
 Why?
Lymph Node Excision
11
2024
164
2.090
 Why?
Pancreatectomy
7
2024
241
1.910
 Why?
Neoplasm Recurrence, Local
16
2025
955
1.700
 Why?
Postoperative Complications
18
2025
2456
1.690
 Why?
Sentinel Lymph Node Biopsy
11
2023
107
1.570
 Why?
Minimally Invasive Surgical Procedures
6
2025
169
1.500
 Why?
Retrospective Studies
75
2025
14404
1.300
 Why?
Survival Rate
32
2025
1870
1.280
 Why?
Tumor Burden
10
2025
283
1.170
 Why?
Databases, Factual
16
2025
1264
1.070
 Why?
Aged
72
2025
21892
1.070
 Why?
Prognosis
35
2025
3766
1.030
 Why?
Liver Transplantation
11
2024
799
0.980
 Why?
Lymph Nodes
8
2024
465
0.980
 Why?
Middle Aged
81
2025
30812
0.950
 Why?
Esophagectomy
4
2021
124
0.920
 Why?
Robotic Surgical Procedures
3
2019
109
0.870
 Why?
Esophageal Neoplasms
7
2023
293
0.860
 Why?
Lymphatic Metastasis
12
2025
317
0.850
 Why?
Conversion to Open Surgery
2
2020
15
0.840
 Why?
Thrombelastography
1
2024
147
0.830
 Why?
Breast Neoplasms
5
2024
2131
0.830
 Why?
Nomograms
2
2022
47
0.820
 Why?
Colorectal Neoplasms
9
2025
746
0.790
 Why?
Carcinoma, Pancreatic Ductal
5
2023
265
0.780
 Why?
Humans
122
2025
128019
0.750
 Why?
Bilirubin
4
2025
92
0.740
 Why?
Rectal Neoplasms
5
2023
136
0.740
 Why?
Female
92
2025
68016
0.720
 Why?
Risk Assessment
15
2025
3223
0.720
 Why?
Male
88
2025
62757
0.700
 Why?
Colonic Neoplasms
3
2024
242
0.610
 Why?
Serum Albumin
5
2025
146
0.610
 Why?
Quality of Life
2
2019
2672
0.570
 Why?
Head and Neck Neoplasms
6
2019
532
0.550
 Why?
Follow-Up Studies
18
2025
4853
0.550
 Why?
Metastasectomy
3
2024
19
0.540
 Why?
Treatment Outcome
26
2025
10110
0.520
 Why?
Neoadjuvant Therapy
11
2023
381
0.520
 Why?
Peritoneal Neoplasms
3
2024
87
0.510
 Why?
Neoplasm Staging
10
2023
1288
0.510
 Why?
Colectomy
3
2013
93
0.490
 Why?
Machine Learning
3
2025
442
0.490
 Why?
Liver Failure
3
2009
91
0.460
 Why?
Stomach Neoplasms
2
2024
97
0.430
 Why?
Axilla
3
2023
45
0.420
 Why?
Cytoreduction Surgical Procedures
3
2024
61
0.400
 Why?
Decision Making
1
2019
846
0.400
 Why?
Propensity Score
4
2024
264
0.390
 Why?
Aged, 80 and over
18
2024
7029
0.370
 Why?
Ampulla of Vater
2
2024
38
0.360
 Why?
Predictive Value of Tests
6
2025
1934
0.360
 Why?
Decision Support Techniques
2
2025
396
0.350
 Why?
Length of Stay
6
2025
1114
0.350
 Why?
ROC Curve
5
2025
500
0.340
 Why?
alpha-Fetoproteins
3
2025
39
0.340
 Why?
Neuroendocrine Tumors
2
2023
97
0.320
 Why?
Benchmarking
2
2021
175
0.310
 Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
10
0.310
 Why?
Adult
35
2025
35176
0.300
 Why?
Gallbladder Neoplasms
2
2024
20
0.300
 Why?
Margins of Excision
4
2023
37
0.290
 Why?
Risk Factors
14
2025
9696
0.280
 Why?
CA-19-9 Antigen
2
2024
22
0.280
 Why?
Mastectomy, Segmental
2
2017
85
0.280
 Why?
Disease-Free Survival
8
2024
647
0.270
 Why?
Liver Cirrhosis
4
2025
279
0.260
 Why?
Catheter Ablation
2
2008
333
0.250
 Why?
Survival Analysis
7
2024
1262
0.250
 Why?
Hyperglycemia
2
2020
326
0.240
 Why?
Infusions, Intra-Arterial
1
2025
54
0.240
 Why?
Time Factors
8
2025
6479
0.240
 Why?
gamma-Glutamyltransferase
1
2025
40
0.240
 Why?
United States
16
2024
13785
0.240
 Why?
Hepatic Artery
1
2025
58
0.240
 Why?
Medical Futility
1
2025
24
0.240
 Why?
Anastomotic Leak
1
2024
38
0.230
 Why?
Blood Loss, Surgical
1
2025
90
0.230
 Why?
Abdomen, Acute
1
2004
18
0.230
 Why?
Quality Indicators, Health Care
2
2025
296
0.230
 Why?
Cohort Studies
10
2023
5378
0.220
 Why?
Preoperative Care
3
2024
335
0.220
 Why?
Bacterial Infections
3
2006
232
0.220
 Why?
Chemotherapy, Adjuvant
6
2025
377
0.220
 Why?
Lymphopenia
1
2024
59
0.220
 Why?
Combined Modality Therapy
6
2024
1199
0.210
 Why?
Odds Ratio
4
2019
1018
0.210
 Why?
Practice Guidelines as Topic
2
2024
1482
0.210
 Why?
SEER Program
2
2014
206
0.210
 Why?
Time-to-Treatment
1
2024
178
0.210
 Why?
Multilocus Sequence Typing
1
2022
13
0.210
 Why?
Lymphoscintigraphy
2
2019
9
0.200
 Why?
Lung Neoplasms
3
2023
2327
0.200
 Why?
Surgical Oncology
1
2022
22
0.200
 Why?
Sunburn
1
2002
26
0.200
 Why?
Sunscreening Agents
1
2002
23
0.200
 Why?
Mastectomy
1
2023
131
0.200
 Why?
Nevus, Pigmented
1
2002
32
0.200
 Why?
Pelvic Exenteration
2
2019
11
0.200
 Why?
Klatskin Tumor
1
2021
14
0.190
 Why?
Anesthetics, Inhalation
1
2021
16
0.180
 Why?
Artificial Intelligence
1
2024
244
0.180
 Why?
Propofol
1
2021
52
0.180
 Why?
Chemoradiotherapy
4
2023
209
0.180
 Why?
Prospective Studies
8
2022
7035
0.170
 Why?
Organ Preservation
4
2023
92
0.170
 Why?
Hyperthermia, Induced
2
2020
108
0.170
 Why?
Proportional Hazards Models
3
2025
1194
0.170
 Why?
Registries
2
2021
1873
0.170
 Why?
Reoperation
3
2017
541
0.160
 Why?
Scalp
1
2019
34
0.160
 Why?
Kaplan-Meier Estimate
3
2025
851
0.160
 Why?
Anesthesia
1
2021
129
0.160
 Why?
Regression Analysis
2
2019
978
0.160
 Why?
Inflammation
3
2024
2646
0.160
 Why?
Neutrophils
1
2024
1192
0.160
 Why?
Pancreatic Diseases
1
2019
67
0.160
 Why?
Skin Pigmentation
1
2019
45
0.150
 Why?
Referral and Consultation
1
2024
724
0.150
 Why?
Tomography, X-Ray Computed
3
2025
2509
0.150
 Why?
Patient Acceptance of Health Care
1
2024
756
0.140
 Why?
Population Surveillance
1
2021
426
0.140
 Why?
Appendiceal Neoplasms
1
2017
26
0.140
 Why?
Neoplasms
2
2022
2460
0.140
 Why?
Common Bile Duct Neoplasms
1
2017
27
0.140
 Why?
Patient Compliance
1
2021
558
0.140
 Why?
Gastric Outlet Obstruction
1
2017
9
0.140
 Why?
Disease Management
1
2021
583
0.140
 Why?
Pylorus
1
2017
17
0.140
 Why?
Waiting Lists
2
2009
237
0.140
 Why?
Carcinoma, Ductal, Breast
1
2017
82
0.140
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1558
0.130
 Why?
Radiotherapy, Intensity-Modulated
1
2018
128
0.130
 Why?
Hospitals, High-Volume
1
2016
39
0.130
 Why?
Cancer Care Facilities
1
2016
32
0.130
 Why?
Nutritional Status
1
2019
326
0.130
 Why?
Neuromuscular Agents
1
2017
30
0.130
 Why?
Botulinum Toxins, Type A
1
2017
39
0.130
 Why?
Hospitals
1
2021
631
0.130
 Why?
Genital Neoplasms, Female
1
2017
81
0.130
 Why?
Patient Reported Outcome Measures
1
2019
368
0.130
 Why?
Cannabis
1
2023
426
0.130
 Why?
Tomography, Emission-Computed, Single-Photon
1
2016
76
0.130
 Why?
Adenoma
1
2017
212
0.120
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
1045
0.120
 Why?
Radiosurgery
1
2018
318
0.120
 Why?
Anti-Bacterial Agents
1
2004
1689
0.110
 Why?
Patient Readmission
1
2019
663
0.110
 Why?
Phenotype
1
2002
3039
0.110
 Why?
Antineoplastic Agents
3
2021
2041
0.110
 Why?
Delivery of Health Care
1
2021
888
0.110
 Why?
Hospital Mortality
4
2024
844
0.110
 Why?
Morbidity
4
2021
301
0.110
 Why?
Unnecessary Procedures
1
2014
48
0.110
 Why?
Trauma Centers
2
2014
400
0.110
 Why?
Abdomen
1
2013
116
0.100
 Why?
Radiation Dosage
1
2014
151
0.100
 Why?
Clinical Competence
1
2019
1007
0.100
 Why?
Renal Insufficiency
1
2013
148
0.090
 Why?
Asia
2
2021
57
0.090
 Why?
Triage
1
2012
205
0.090
 Why?
Age Factors
4
2022
3100
0.080
 Why?
Carcinoma, Renal Cell
1
2012
179
0.080
 Why?
Europe
2
2021
359
0.080
 Why?
Logistic Models
2
2025
1975
0.080
 Why?
Kidney Transplantation
2
2013
603
0.080
 Why?
Organ Preservation Solutions
2
2006
43
0.080
 Why?
Brain Injuries
1
2014
463
0.080
 Why?
Graft Survival
2
2009
503
0.080
 Why?
Practice Patterns, Physicians'
1
2017
1260
0.080
 Why?
Diagnostic Tests, Routine
2
2024
101
0.080
 Why?
Laparotomy
1
2008
106
0.070
 Why?
Bile Ducts, Extrahepatic
1
2008
22
0.070
 Why?
Kidney Neoplasms
1
2012
349
0.070
 Why?
Biliary Tract Surgical Procedures
1
2008
25
0.070
 Why?
Case-Control Studies
2
2007
3324
0.070
 Why?
Neoplasm Invasiveness
3
2020
477
0.070
 Why?
Intraoperative Care
1
2007
45
0.070
 Why?
Young Adult
7
2022
12281
0.070
 Why?
Cholangitis, Sclerosing
1
2008
70
0.070
 Why?
Electrocoagulation
1
2007
38
0.070
 Why?
Anus Neoplasms
1
2007
30
0.070
 Why?
Guideline Adherence
2
2024
523
0.070
 Why?
Congenital Hypothyroidism
1
1986
11
0.070
 Why?
Brazil
2
2008
154
0.070
 Why?
Multivariate Analysis
2
2025
1492
0.070
 Why?
Ultrasonography, Interventional
1
2007
128
0.070
 Why?
Fluorouracil
2
2022
197
0.060
 Why?
Wounds and Injuries
1
2012
705
0.060
 Why?
Mycophenolic Acid
1
2006
89
0.060
 Why?
Pandemics
2
2023
1473
0.060
 Why?
Adolescent
9
2022
20158
0.060
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
26
0.060
 Why?
Serum Albumin, Human
1
2024
5
0.060
 Why?
Platelet Count
1
2024
82
0.060
 Why?
Sample Size
1
2025
115
0.060
 Why?
Severity of Illness Index
2
2009
2703
0.060
 Why?
Lymphocyte Count
1
2024
150
0.060
 Why?
Radiotherapy, Adjuvant
2
2019
209
0.060
 Why?
Zygomycosis
1
2003
6
0.060
 Why?
Gastrectomy
1
2024
99
0.050
 Why?
Bile Ducts, Intrahepatic
1
2024
65
0.050
 Why?
Developmental Disabilities
1
1986
258
0.050
 Why?
Cluster Analysis
1
2025
477
0.050
 Why?
Comorbidity
2
2022
1537
0.050
 Why?
Antibiotic Prophylaxis
1
2004
101
0.050
 Why?
Hepatocytes
1
2004
213
0.050
 Why?
Lymphocytes
1
2024
367
0.050
 Why?
Appendicitis
1
2004
125
0.050
 Why?
Biology
1
2023
83
0.050
 Why?
Capecitabine
1
2022
46
0.050
 Why?
Carcinoma, Squamous Cell
1
2007
620
0.050
 Why?
Pneumonectomy
1
2023
151
0.050
 Why?
Anesthesia, Intravenous
1
2021
11
0.050
 Why?
Anesthetics, Intravenous
1
2021
38
0.050
 Why?
Esophagogastric Junction
1
2021
50
0.040
 Why?
Surgical Wound Infection
1
2004
281
0.040
 Why?
Models, Biological
1
2008
1689
0.040
 Why?
Induction Chemotherapy
1
2021
70
0.040
 Why?
Body Mass Index
2
2024
2260
0.040
 Why?
Liver
2
2006
1826
0.040
 Why?
Thoracoscopy
1
2020
50
0.040
 Why?
Medical Oncology
1
2022
271
0.040
 Why?
Societies, Medical
1
2024
741
0.040
 Why?
Image-Guided Biopsy
1
2019
37
0.040
 Why?
Adenocarcinoma, Mucinous
1
2020
75
0.040
 Why?
Preoperative Period
1
2019
113
0.040
 Why?
Biomarkers, Tumor
1
2024
1175
0.040
 Why?
Oxidative Stress
1
2004
1181
0.040
 Why?
Perioperative Period
1
2017
48
0.040
 Why?
Carcinoma, Lobular
1
2017
48
0.030
 Why?
Occipital Bone
1
2017
18
0.030
 Why?
Operative Time
1
2017
121
0.030
 Why?
Parotid Gland
1
2017
21
0.030
 Why?
Gastric Emptying
1
2017
40
0.030
 Why?
Obesity
1
2010
2859
0.030
 Why?
Health Behavior
1
2002
740
0.030
 Why?
Longitudinal Studies
1
2024
2706
0.030
 Why?
Neck
1
2017
92
0.030
 Why?
Perioperative Care
1
2018
149
0.030
 Why?
Sex Factors
1
2022
1942
0.030
 Why?
Raffinose
2
2006
21
0.030
 Why?
Allopurinol
2
2006
60
0.030
 Why?
Glucose
1
2020
983
0.030
 Why?
Consensus
1
2017
607
0.030
 Why?
Adenosine
2
2006
212
0.030
 Why?
Drug Administration Schedule
1
2015
755
0.030
 Why?
Glutathione
2
2006
340
0.030
 Why?
Cross-Sectional Studies
2
2022
5034
0.030
 Why?
Glasgow Coma Scale
1
2014
167
0.030
 Why?
Magnetic Resonance Imaging
1
2025
3371
0.030
 Why?
Radiation Injuries
1
2014
135
0.030
 Why?
Incidence
1
2019
2614
0.030
 Why?
Vital Signs
1
2012
41
0.030
 Why?
New South Wales
1
2012
14
0.030
 Why?
Child
6
2014
20636
0.020
 Why?
Baltimore
1
2012
44
0.020
 Why?
Disease Progression
1
2020
2598
0.020
 Why?
Italy
1
2012
97
0.020
 Why?
Child, Preschool
4
2014
10378
0.020
 Why?
Hospital Costs
1
2012
114
0.020
 Why?
Pharmaceutical Preparations
1
2013
168
0.020
 Why?
Biological Therapy
1
2011
28
0.020
 Why?
Albuminuria
1
1992
181
0.020
 Why?
Chi-Square Distribution
1
2012
511
0.020
 Why?
Injury Severity Score
1
2012
509
0.020
 Why?
Lung
1
2023
3745
0.020
 Why?
Surveys and Questionnaires
1
2022
5353
0.020
 Why?
Glomerular Filtration Rate
1
2013
682
0.020
 Why?
Immunosuppressive Agents
1
2013
682
0.020
 Why?
Infant, Newborn
2
2014
5688
0.020
 Why?
Carcinoembryonic Antigen
1
2008
41
0.020
 Why?
Antimetabolites, Antineoplastic
1
2008
90
0.020
 Why?
Radiopharmaceuticals
1
2008
166
0.020
 Why?
Infant
3
2014
8912
0.020
 Why?
Sensitivity and Specificity
1
2012
1813
0.020
 Why?
Fluorodeoxyglucose F18
1
2008
127
0.020
 Why?
Colorado
1
2017
4369
0.020
 Why?
Retreatment
1
2007
69
0.020
 Why?
Cholecystectomy
1
2007
59
0.020
 Why?
Positron-Emission Tomography
1
2008
283
0.020
 Why?
Incidental Findings
1
2007
79
0.020
 Why?
Neoplasm, Residual
1
2007
119
0.020
 Why?
Biopsy, Needle
1
2007
187
0.020
 Why?
Tablets, Enteric-Coated
1
2006
4
0.020
 Why?
Hepatitis B
1
2007
60
0.020
 Why?
Histidine
1
2006
58
0.020
 Why?
Radiography
1
2008
794
0.020
 Why?
Psychological Tests
1
1986
130
0.020
 Why?
Overweight
1
2010
522
0.020
 Why?
Graft Rejection
1
2009
557
0.010
 Why?
Tryptophan
1
2006
171
0.010
 Why?
Insulin
2
2006
2316
0.010
 Why?
Glutathione Disulfide
1
2004
31
0.010
 Why?
Hepatitis C
1
2007
234
0.010
 Why?
Sulfamethoxypyridazine
1
1983
1
0.010
 Why?
Trimethoprim
1
1983
7
0.010
 Why?
Gastrointestinal Diseases
1
2006
196
0.010
 Why?
Liver Function Tests
1
2004
107
0.010
 Why?
Anti-Infective Agents, Urinary
1
1983
13
0.010
 Why?
Amphotericin B
1
2003
29
0.010
 Why?
Liver Diseases
1
2006
285
0.010
 Why?
Patient Selection
1
2007
658
0.010
 Why?
Antifungal Agents
1
2003
128
0.010
 Why?
Cause of Death
1
2004
392
0.010
 Why?
Immunocompromised Host
1
2003
195
0.010
 Why?
Urinary Tract Infections
1
1983
144
0.010
 Why?
Reperfusion Injury
1
2004
264
0.010
 Why?
Cardiovascular Diseases
1
1992
1994
0.010
 Why?
Diabetes Mellitus, Type 1
1
1992
3625
0.010
 Why?
Cholesterol
1
1992
406
0.010
 Why?
Blood Pressure
1
1992
1711
0.000
 Why?
Sulfamethoxazole
1
1983
7
0.000
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1983
37
0.000
 Why?
Escherichia coli Infections
1
1983
105
0.000
 Why?
Drug Combinations
1
1983
323
0.000
 Why?
Microbial Sensitivity Tests
1
1983
348
0.000
 Why?
Escherichia coli
1
1983
766
0.000
 Why?
Clinical Trials as Topic
1
1983
997
0.000
 Why?
Gleisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (331) concept(s)
_
Co-Authors Expand Description
See all (43) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)